Literature DB >> 27101989

Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.

Samantha L Hersrud1, Attila D Kovács1, David A Pearce2.   

Abstract

Mutations of the CLN3 gene lead to juvenile neuronal ceroid lipofuscinosis (JNCL), an autosomal recessive lysosomal storage disorder that causes progressive neurodegeneration in children and adolescents. There is evidence of immune system involvement in pathology that has been only minimally investigated. We characterized bone marrow stem cell-derived antigen presenting cells (APCs), peritoneal macrophages, and leukocytes from spleen and blood, harvested from the Cln3(-/-) mouse model of JNCL. We detected dramatically elevated CD11c surface levels and increased total CD11c protein in Cln3(-/-) cell samples compared to wild type. This phenotype was specific to APCs and also to a loss of CLN3, as surface levels did not differ from wild type in other leukocyte subtypes nor in cells from two other NCL mouse models. Subcellularly, CD11c was localized to lipid rafts, indicating that perturbation of surface levels is attributable to derangement of raft dynamics, which has previously been shown in Cln3 mutant cells. Interrogation of APC function revealed that Cln3(-/-) cells have increased adhesiveness to CD11c ligands as well as an abnormal secretory pattern that closely mimics what has been previously reported for Cln3 mutant microglia. Our results show that CLN3 deficiency alters APCs, which can be a major contributor to the autoimmune response in JNCL.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Batten disease; CD11c; CLN3; Integrin; JNCL

Mesh:

Substances:

Year:  2016        PMID: 27101989      PMCID: PMC4899816          DOI: 10.1016/j.bbadis.2016.04.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  91 in total

1.  Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface.

Authors:  L J Miller; D F Bainton; N Borregaard; T A Springer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

2.  Cholera toxin: interaction of subunits with ganglioside GM1.

Authors: 
Journal:  Science       Date:  1974-02-15       Impact factor: 47.728

3.  IgA nephropathy in two adolescent sisters heterozygous for Fabry disease.

Authors:  Catharina Whybra; Andreas Schwarting; Jörg Kriegsmann; Andreas Gal; Eugen Mengel; Christoph Kampmann; Frank Baehner; Ellen Schaefer; Michael Beck
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

4.  Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].

Authors:  H M Mitchison; D J Bernard; N D Greene; J D Cooper; M A Junaid; R K Pullarkat; N de Vos; M H Breuning; J W Owens; W C Mobley; R M Gardiner; B D Lake; P E Taschner; R L Nussbaum
Journal:  Neurobiol Dis       Date:  1999-10       Impact factor: 5.996

5.  An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.

Authors:  Subrata Chattopadhyay; Masumi Ito; Jonathan D Cooper; Andrew I Brooks; Timothy M Curran; James M Powers; David A Pearce
Journal:  Hum Mol Genet       Date:  2002-06-01       Impact factor: 6.150

6.  B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy.

Authors:  Diego Catalán; Octavio Aravena; Francisca Sabugo; Pamela Wurmann; Lilian Soto; Alexis M Kalergis; Miguel Cuchacovich; Juan C Aguillón
Journal:  Arthritis Res Ther       Date:  2010-04-15       Impact factor: 5.156

7.  Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals.

Authors:  David Patsouris; Ping-Ping Li; Divya Thapar; Justin Chapman; Jerrold M Olefsky; Jaap G Neels
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

8.  CLN3 loss disturbs membrane microdomain properties and protein transport in brain endothelial cells.

Authors:  Luis Tecedor; Colleen S Stein; Mark L Schultz; Hany Farwanah; Konrad Sandhoff; Beverly L Davidson
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

9.  Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice.

Authors:  Ian M Williams; Kerri-Lee Wallom; David A Smith; Nada Al Eisa; Claire Smith; Frances M Platt
Journal:  Neurobiol Dis       Date:  2014-03-12       Impact factor: 5.996

10.  Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1.

Authors:  Anneliese O Speak; Danielle Te Vruchte; Lianne C Davis; Anthony J Morgan; David A Smith; Nicole M Yanjanin; Louise Simmons; Ralf Hartung; Heiko Runz; Eugen Mengel; Michael Beck; Jackie Imrie; Elizabeth Jacklin; James E Wraith; Christian Hendriksz; Robin Lachmann; Celine Cognet; Rohini Sidhu; Hideji Fujiwara; Daniel S Ory; Antony Galione; Forbes D Porter; Eric Vivier; Frances M Platt
Journal:  Blood       Date:  2013-11-14       Impact factor: 22.113

View more
  1 in total

1.  Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis.

Authors:  Gemma Gomez-Giro; Jonathan Arias-Fuenzalida; Javier Jarazo; Dagmar Zeuschner; Muhammad Ali; Nina Possemis; Silvia Bolognin; Rashi Halder; Christian Jäger; Willemijn F E Kuper; Peter M van Hasselt; Holm Zaehres; Antonio Del Sol; Herman van der Putten; Hans R Schöler; Jens C Schwamborn
Journal:  Acta Neuropathol Commun       Date:  2019-12-30       Impact factor: 7.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.